XXII

#5050
22nd Century Group, Inc - Common Stock
2.4 5 USD
+0.07%
Market Price
Settore: Beni di Consumo Difensivi
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
2.45
2.45
Intervallo Annuale
0.27
7.32
Variazione giornaliera
+7.46%
Variazione Mensile
-42.89%
Variazione di 6 mesi
-38.10%
Variazione Annuale
-57.02%
Chiusura Precedente
2.2 8
Open
2.4 5
Minimo
2.4 5
Massimo
2.4 5
Volume
1
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche Documents

2026

Current report, 01 Sep 2026
22Nd Century Group, Inc. current report, 01 September 2026
8-K
Current report, Q3 FY2026
22Nd Century Group, Inc. current report, Q3 FY2026
8-K
Current report, Q3 FY2026
22Nd Century Group, Inc. current report, Q3 FY2026
8-K
Current report, Q3 FY2026
22Nd Century Group, Inc. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
22Nd Century Group, Inc. quarterly report, Q2 FY2026
10-Q
Current report, Q2 FY2026
22Nd Century Group, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
22Nd Century Group, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
22Nd Century Group, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
22Nd Century Group, Inc. current report, Q2 FY2026
8-K
Quarterly report, Q1 FY2026
22Nd Century Group, Inc. quarterly report, Q1 FY2026
10-Q

22Nd Century Group, Inc. current report, 07 November 2023

Full document

Business Context and Reporting Period

This Form 8-K filing by 22nd Century Group, Inc. (Nasdaq: XXII) was submitted on November 10, 2023, reporting an event that occurred on November 7, 2023. The Company is incorporated in Nevada and operates its principal executive office in Buffalo, New York.

Key Financial Metrics

This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The report focuses exclusively on regulatory compliance regarding stock listing standards.

Material Changes

The Company received a deficiency letter from the Nasdaq Listing Qualifications Department indicating noncompliance with the Minimum Bid Price Requirement (Rule 5550(a)(2)). Specifically, the Company's common stock failed to maintain a minimum closing bid price of $1.00 per share for the last 31 consecutive business days prior to the notification.

Outlook, Risks, and Management Commentary

  • Compliance Period: The Company has 180 calendar days from the notification date, or until May 6, 2024, to regain compliance.
  • Regaining Compliance: To cure the deficiency, the closing bid price must be at or above $1.00 for a minimum of 10 consecutive business days within the initial 180-day period.
  • Secondary Compliance Period: If the Company fails to regain compliance by May 6, 2024, it may be eligible for a second 180-day period. Qualification for this period requires meeting the market value of publicly held shares requirement and all other initial listing standards for the Nasdaq Capital Market, excluding the bid price requirement.
  • Immediate Impact: The notification has no immediate effect on the listing or trading of the Company's common stock.
  • Management Action: The Company intends to monitor the closing bid price and may consider implementing available options to regain compliance.

Investor Verification Checklist

  • Verify the current closing bid price of XXII stock relative to the $1.00 threshold.
  • Monitor the stock price for 10 consecutive business days to determine if the initial compliance period is met.
  • Review the Company's market value of publicly held shares to assess eligibility for a potential second compliance period.
  • Watch for future announcements regarding reverse stock splits or other corporate actions intended to address the bid price deficiency.

Notizie